Alectinib User Reviews & Ratings
Brand names: Alecensa
Alectinib has an average rating of 9.5 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Non Small Cell Lung Cancer | 2 reviews for Non Small Cell Lung Cancer | 57 medications | |
Add your review |
- Kerri
- Taken for 6 months to 1 year
- December 28, 2018
Alecensa (alectinib) for Non Small Cell Lung Cancer "After using Optivo, 12 rounds of Chemo, now Alecensa it has finally helped my stage 4 lung cancer. It has very few side effects compared to using other targeted and immuno therapy related drugs."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about alectinib
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Alecensa (alectinib) for Non Small Cell Lung Cancer "Taking from last 12 months regularly lungs has been cleared in PET CT Report some metastases are in brain. Doctor advised me to continue for 4 months more. It is easy to swallow but constipation is main problem occurred to me."